Geode Capital Management’s Vivani Medical VANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $601K | Buy |
600,578
+138,926
| +30% | +$174K | ﹤0.01% | 3522 |
|
|
2025
Q4 | $568K | Buy |
461,652
+105,398
| +30% | +$152K | ﹤0.01% | 3544 |
|
|
2025
Q3 | $502K | Buy |
356,254
+2,356
| +0.7% | +$3.19K | ﹤0.01% | 3614 |
|
|
2025
Q2 | $457K | Sell |
353,898
-6,628
| -2% | -$7.31K | ﹤0.01% | 3587 |
|
|
2025
Q1 | $379K | Buy |
360,526
+13,374
| +4% | +$15.4K | ﹤0.01% | 3644 |
|
|
2024
Q4 | $403K | Buy |
347,152
+4,261
| +1% | +$5.39K | ﹤0.01% | 3678 |
|
|
2024
Q3 | $401K | Buy |
342,891
+15,008
| +5% | +$18.8K | ﹤0.01% | 3679 |
|
|
2024
Q2 | $413K | Buy |
327,883
+12,952
| +4% | +$22.2K | ﹤0.01% | 3637 |
|
|
2024
Q1 | $583K | Buy |
314,931
+117,790
| +60% | +$173K | ﹤0.01% | 3552 |
|
|
2023
Q4 | $201K | Hold |
197,141
| – | – | ﹤0.01% | 3941 |
|
|
2023
Q3 | $201K | Buy |
197,141
+54,591
| +38% | +$60.1K | ﹤0.01% | 3977 |
|
|
2023
Q2 | $172K | Buy |
142,550
+45,503
| +47% | +$56K | ﹤0.01% | 4104 |
|
|
2023
Q1 | $97K | Buy |
97,047
+4,545
| +5% | +$5.05K | ﹤0.01% | 4345 |
|
|
2022
Q4 | $78K | Buy |
92,502
+7,063
| +8% | +$11.5K | ﹤0.01% | 4481 |
|
|
2022
Q3 | $194K | Sell |
85,439
-2
| -0% | -$9 | ﹤0.01% | 4230 |
|
|
2022
Q2 | $520K | Buy |
85,441
+12,743
| +18% | +$68.7K | ﹤0.01% | 3738 |
|
|
2022
Q1 | $311K | Buy |
72,698
+14,102
| +24% | +$59.3K | ﹤0.01% | 4167 |
|
|
2021
Q4 | $286K | Buy |
58,596
+10,537
| +22% | +$77K | ﹤0.01% | 4313 |
|
|
2021
Q3 | $459K | Sell |
48,059
-783
| -2% | -$8.82K | ﹤0.01% | 4069 |
|
|
2021
Q2 | $723K | Buy |
48,842
+13,050
| +36% | +$252K | ﹤0.01% | 3760 |
|
|
2021
Q1 | $885K | Buy |
35,792
+11,711
| +49% | +$175K | ﹤0.01% | 3607 |
|
|
2020
Q4 | $135K | Buy |
24,081
+14,268
| +145% | +$50.4K | ﹤0.01% | 4002 |
|
|
2020
Q3 | $25K | Hold |
9,813
| – | – | ﹤0.01% | 4105 |
|
|
2020
Q2 | $28K | Hold |
9,813
| – | – | ﹤0.01% | 4050 |
|
|
2020
Q1 | $29K | Buy |
9,813
+92
| +0.9% | +$1.21K | ﹤0.01% | 4007 |
|
|
2019
Q4 | $173K | Buy |
9,721
+57
| +0.6% | +$1.12K | ﹤0.01% | 3843 |
|
|
2019
Q3 | $191K | Hold |
9,664
| – | – | ﹤0.01% | 3789 |
|
|
2019
Q2 | $185K | Buy |
9,664
+1,594
| +20% | +$32.7K | ﹤0.01% | 3808 |
|
|
2019
Q1 | $153K | Hold |
8,070
| – | – | ﹤0.01% | 3803 |
|
|
2018
Q4 | $171K | Hold |
8,070
| – | – | ﹤0.01% | 3717 |
|
|
2018
Q3 | $368K | Buy |
8,070
+777
| +11% | +$31.4K | ﹤0.01% | 3572 |
|
|
2018
Q2 | $290K | Buy |
7,293
+3,066
| +73% | +$133K | ﹤0.01% | 3613 |
|
|
2018
Q1 | $194K | Hold |
4,227
| – | – | ﹤0.01% | 3703 |
|
|
2017
Q4 | $193K | Sell |
4,227
-735
| -15% | -$24.4K | ﹤0.01% | 3687 |
|
|
2017
Q3 | $142K | Hold |
4,962
| – | – | ﹤0.01% | 3743 |
|
|
2017
Q2 | $150K | Sell |
4,962
-964
| -16% | -$27.3K | ﹤0.01% | 3763 |
|
|
2017
Q1 | $172K | Buy |
5,926
+628
| +12% | +$24.1K | ﹤0.01% | 3704 |
|
|
2016
Q4 | $250K | Buy |
5,298
+1,352
| +34% | +$77.2K | ﹤0.01% | 3534 |
|
|
2016
Q3 | $333K | Sell |
3,946
-1,855
| -32% | -$164K | ﹤0.01% | 3416 |
|
|
2016
Q2 | $498K | Buy |
5,801
+1,826
| +46% | +$190K | ﹤0.01% | 3227 |
|
|
2016
Q1 | $460 | Buy |
3,975
+32
| +0.8% | +$3.68K | ﹤0.01% | 3274 |
|
|
2015
Q4 | $557K | Buy |
3,943
+1,742
| +79% | +$255K | ﹤0.01% | 3224 |
|
|
2015
Q3 | $313K | Buy |
2,201
+600
| +37% | +$167K | ﹤0.01% | 3467 |
|
|
2015
Q2 | $522K | Buy |
1,601
+518
| +48% | +$166K | ﹤0.01% | 3172 |
|
|
2015
Q1 | $333K | Buy |
1,083
+576
| +114% | +$160K | ﹤0.01% | 3376 |
|
|
2014
Q4 | $124K | Buy |
+507
| New | +$177K | ﹤0.01% | 3735 |
|
Other funds holding VANI
VCM
TWM
VFT
MMG
Geode Capital Management's VANI Position: Q1 2026 in Review
Geode Capital Management increased its Vivani Medical (VANI) stake by 30% in Q1 2026, buying an estimated $174K and bringing the position to 600,578 shares worth $601K. The position accounts for ﹤0.01% of the portfolio, ranked #3522.
Geode Capital Management first reported a position in VANI in Q4 2014 and has held it in 46 quarters since. The position peaked at $885K in Q1 2021. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.
- Geode Capital Management held 600,578 shares of Vivani Medical worth $601K as of Q1 2026.
- Geode Capital Management bought 138,926 Vivani Medical shares in Q1 2026, an estimated $174K.
- Vivani Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3522 holding.
- Geode Capital Management first reported a position in Vivani Medical in Q4 2014 and has held it in 46 quarters since.
- Geode Capital Management's Vivani Medical position peaked at $885K in Q1 2021.
- 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.